artificial intelligence They are outpacing doctors in detecting cancers common in men.
A new UCLA study found that AI tools identified prostate cancer with 84% accuracy, compared with 67% accuracy for doctor-detected cases, according to a UCLA press release.
Developed by California-based Avenda Health, Unfold AI is a U.S. Food and Drug Administration-approved software that uses AI algorithms to: Possible cancer It is based on different types of clinical data.
What is Artificial Intelligence?
In this study, a team of seven urologists and three radiologists 50 cases analyzed The area where the tumor was removed will be looked for signs of remaining cancer.
A few months later, the AI software ran the same analysis.
A new study from UCLA found that AI tools identified prostate cancer with 84% accuracy, compared with 67% accuracy for doctor-detected cases. (iStock)
“The ‘negative margin rate’ – the medical term for the absence of cancer cells around the removed tissue – was 45 times higher in the AI-detected cases, meaning that cancer was much less likely to remain.
Dr. Ali Kasreian, a urologist at Kasreian Urology in Jacksonville, Florida, said he uses Unfold AI technology in his patient consultations. Prostate Cancer Management.
AI can predict whether cancer treatment will work, expert says: ‘Exciting times for medicine’
“The AI takes the information we currently have about a patient’s prostate cancer, including pathology, imaging and biopsy results, and creates a 3D estimated cancer map,” he told Fox News Digital in an email.
“Results from Unfold AI will inform whether a patient is suitable for localized therapy or more definitive treatments such as radical prostatectomy or radiation therapy, optimizing cancer care and ensuring it is personalized for the patient. Cancer Treatmentand quality of life goals.”
“AI is our new diagnostic ally. But like any tool, AI works best in human hands.”
Based on these findings, the researchers write, AI could lead to more accurate diagnoses and more targeted treatments, potentially reducing the need for removal of the entire gland and its associated side effects, such as incontinence and impotence.
‘Major breakthrough’: AI model could help predict lung cancer risk in non-smokers, study finds
Dr. Joshua Truckenberg, a professor of neurobiology at UCLA and a prostate cancer patient, said that when doctors found a slow-growing tumor in his prostate and recommended surgically removing it, he decided to explore other options.
“I have been in contact with a team at UCLA, where I am also a faculty member, to explore alternatives to a complete gland removal,” Truckenberg, 56, told Fox News Digital in an email.
“The ‘negative margin rate’ – a medical term that refers to the absence of cancer cells around the removed tissue – was 45 times higher in the AI-detected cases, meaning that residual cancer was much less likely. (iStock)
The UCLA researchers were testing a technique that uses ultrasound to heat tissue and then “guid[s]” it with MRI to destroy the cancerous tissue without damaging the rest of the gland, he said.
After several imaging scans, it was determined that Trachenberg was a candidate for the experimental treatment.
AI tech aims to mimic radiologists’ eye movements to detect breast cancer: ‘An important friend’
“The 3D map created by Unfold AI enabled the team to identify the exact borders, target the cancerous areas and avoid the functional structures of the gland,” he said.
“It helped me visualize my cancer and give me a better understanding of my symptoms.”
“It really helped me visualize my cancer and understand my symptoms better.”
Trachenberg is now cancer-free and was able to avoid radical prostate removal surgery.
“I would encourage prostate cancer patients who have been told they need radical prostatectomy to take the time to consider all their options. [including] “AI technology,” said the doctor and patient (not pictured). (iStock)
“Many men are afraid of the treatment because of the risks associated with removing the glands. Unfold AI makes it possible to have a treatment that doesn’t put men through the meat grinder,” he said.
This kind of AI technology gives Trachenberg hope for the future. Prostate Cancer Treatmenthe told Fox News Digital.
Click here to get the FOX News app
“In many cases we are given only two options: either let it get worse or remove the entire gland, which often leaves people with lifelong side effects that put a strain on their physical and mental health and even their marriages,” he said.
“I would encourage prostate cancer patients who have been told they need radical prostatectomy to take the time to consider all their options. [including] “AI Technology”
Potential risks and limitations
Dr. Harvey Castro Emergency physician The Dallas, Texas-based national speaker on artificial intelligence was not involved in the new research but offered his views on potential risks associated with the technology.
Dr. Harvey Castro, a board-certified emergency physician based in Dallas, Texas, and national speaker on artificial intelligence, shared his perspective on the potential risks associated with the technology. (Dr. Harvey Castro)
“The accuracy of AI depends heavily on the quality of the data it is trained on,” he told Fox News Digital. “Poor quality data can lead to inaccurate diagnoses.”
Click here to sign up for our Health Newsletter
Castro also warned against “over-reliance” on AI.
“AI is a powerful tool, but it must complement, not replace, the clinical judgement of medical professionals,” he said.
“AI is our new diagnostic ally,” Castro added, “but like any tool, AI works best in human hands.”
“AI is a powerful tool, but it must complement, not replace, the clinical judgement of medical professionals,” the experts said. (iStock)
Privacy should also be considered when using this. Type of TechnologyAccording to Castro.
“Handling sensitive patient data with AI requires strict data protection measures to maintain patient trust and confidentiality.”
For more health related articles, Fox News
The cost of AI technology could also be a major barrier, Kasreian added.
“We hope this study will encourage us and future payers to make these innovations more accessible to urologists and, most importantly, patients.”
